Evidence map›Paper›PMID 37940989›Full record

ArticleVirology journal2023

Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron.

Simon Schröder, Anja Richter, Talitha Veith, Jackson Emanuel, Luca Gudermann, Kirstin Friedmann, Lara M Jeworowski, Barbara Mühlemann, Terry C Jones, Marcel A Müller and 2 more

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Simon SchröderInstitute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Anja RichterInstitute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Talitha VeithInstitute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Jackson EmanuelInstitute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Luca GudermannInstitute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Kirstin FriedmannInstitute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Lara M JeworowskiInstitute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Barbara MühlemannInstitute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Terry C JonesInstitute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Marcel A MüllerInstitute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Victor M CormanInstitute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Christian DrostenInstitute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany. christian.drosten@charite.de.
Charité - Universitätsmedizin Berlin · DE

Funding

NIAID NIH HHS HHSN272201400008C
6 · The paper itself

Abstract

backgroundIntrinsic fitness costs are likely to have guided the selection of lineage-determining mutations during emergence of variants of SARS-CoV-2. Whereas changes in receptor affinity and antibody neutralization have been thoroughly mapped for individual mutations in spike, their influence on intrinsic replicative fitness remains understudied.

methodsWe analyzed mutations in immunodominant spike epitope E484 that became temporarily fixed over the pandemic. We engineered the resulting immune escape mutations E484K, -A, and -Q in recombinant SARS-CoV-2. We characterized viral replication, entry, and competitive fitness with and without immune serum from humans with defined exposure/vaccination history and hamsters monospecifically infected with the E484K variant. We additionally engineered a virus containing the Omicron signature mutations N501Y and Q498R that were predicted to epistatically enhance receptor binding.

resultsMultistep growth kinetics in Vero-, Calu-3, and NCI-H1299 were identical between viruses. Synchronized entry experiments based on cold absorption and temperature shift identified only an insignificant trend toward faster entry of the E484K variant. Competitive passage experiments revealed clear replicative fitness differences. In absence of immune serum, E484A and E484Q, but not E484K, were replaced by wildtype (WT) in competition assays. In presence of immune serum, all three mutants outcompeted WT. Decreased E484A fitness levels were over-compensated for by N501Y and Q498R, identifying a putative Omicron founder background that exceeds the intrinsic and effective fitness of WT and matches that of E484K. Critically, the E484A/Q498R/N501Y mutant and E484K have equal fitness also in presence of pre-Omicron vaccinee serum, whereas the fitness gain by E484K is lost in the presence of serum raised against the E484K variant in hamsters.

conclusionsThe emergence of E484A and E484Q prior to widespread population immunity may have been limited by fitness costs. In populations already exposed to the early immune escape epitope E484K, the Omicron founder background may have provided a basis for alternative immune escape evolution via E484A. Studies of major antigenic epitope changes with and without their epistatic context help reconstruct the sequential adjustments of intrinsic fitness versus neutralization escape during the evolution of major SARS-CoV-2 variants in an increasingly immune human population.

Indexed as

COVID-19SARS-CoV-2AnimalsAntibodies, NeutralizingCricetinaeEpitopesHumansImmune SeraImmunodominant EpitopesMutationSpike Glycoprotein, CoronavirusAntibodies, NeutralizingEpitopesImmune SeraImmunodominant EpitopesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Antibody neutralization escapeCOVID-19Epitope E484Reverse geneticsSARS-CoV-2Spike protein evolutionVirus fitness

Identifiers

PMID37940989
PMCPMC10633978
OpenAlexW4388501020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.